Role of Tivozanib in Renal Cell Carcinoma (RCC) - Episode 3
Dr Thomas Hutson reviews the adverse event profile of tivozanib and provides advice to community oncologists on how to best manage these toxicities.
4 Recent FDA-Approved Blood Cancer Drugs That Patients May Have Missed
Standing on My Hereditary Cancer Awareness and Prevention Soapbox
FDA to Speed Up Review of Novel Drug for Mesothelioma Not Treatable by Surgery
Educated Patient® Metastatic Breast Cancer Summit Supportive Care Presentation: June 11, 2022